English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Shorter telomeres associated with high doses of glucocorticoids: the link to increased mortality?

MPS-Authors
/persons/resource/persons124315

Athanasoulia-Kaspar,  Anastasia P.
RG Clinical Neuroendocrinology, Clinical Research, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons127670

Auer,  Matthias K.
RG Clinical Neuroendocrinology, Clinical Research, Max Planck Institute of Psychiatry, Max Planck Society;
External Organizations;

/persons/resource/persons80539

Stalla,  Guenter K.
RG Clinical Neuroendocrinology, Clinical Research, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons123271

Jakovcevski,  Mira
Dept. Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Supplementary Material (public)
There is no public supplementary material available
Citation

Athanasoulia-Kaspar, A. P., Auer, M. K., Stalla, G. K., & Jakovcevski, M. (2018). Shorter telomeres associated with high doses of glucocorticoids: the link to increased mortality? ENDOCRINE CONNECTIONS, 7(11), 1217-1226. doi:10.1530/EC-18-0362.


Cite as: https://hdl.handle.net/21.11116/0000-0003-8F9A-F
Abstract
Objective: Patients with non-functioning pituitary adenomas exhibit high morbidity and mortality rates. Growth hormone deficiency and high doses of glucocorticoid substitution therapy have been identified as corresponding risk factors. Interestingly, high levels of endogenous cortisol in, e.g., patients with post-traumatic stress disorder or patients with Cushing's disease have been linked to shorter telomere length. Telomeres are noncoding DNA regions located at the end of chromosomes consisting of repetitive DNA sequences which shorten with aging and hereby determine cell survival. Therefore, telomere length can serve as a predictor for the onset of disease and mortality in some endocrine disorders (e.g., Cushing's disease).
Design/methods: Here, we examine telomere length from blood in patients (n=115) with non-functioning pituitary adenomas (NFPA) in a cross-sectional case-control (n= 106, age-, gender-matched) study using qPCR. Linear regression models were used to identify independent predictors of telomere length.
Results: We show that patients with NFPA exhibited shorter telomeres than controls. No significant association of indices of growth hormone deficiency (IGF-1-level-SDS, years of unsubstituted growth hormone deficiency etc.) with telomere length was detected. Interestingly, linear regression analysis showed that hydrocortisone replacement dosage in patients with adrenal insufficiency (n=52) was a significant predictor for shorter telomere length (beta=0.377; P=0.018) independent of potential confounders (gender, age, BMI, arterial hypertension, systolic blood pressure, number of antihypertensive drugs, total leukocyte count, waist-to-hip ratio, waist circumference, diabetes mellitus type 2, HbA1c, current statin use). Median split analysis revealed that higher hydrocortisone intake (>20 mg) was associated with significantly shorter telomeres.
Conclusion: These observations strengthen the importance of adjusted glucocorticoid treatment in NFPA patients with respect to morbidity and mortality rates.